Quentin Rodney Regestein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hot Flashes | 5 | 2017 | 329 | 1.690 |
Why?
|
| Postmenopause | 7 | 2018 | 2517 | 1.570 |
Why?
|
| Menopause | 11 | 2017 | 1656 | 1.070 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 16 | 2014 | 1104 | 0.940 |
Why?
|
| Sleep | 12 | 2016 | 4814 | 0.450 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2014 | 982 | 0.450 |
Why?
|
| Problem Solving | 1 | 2016 | 442 | 0.430 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2014 | 153 | 0.430 |
Why?
|
| Perimenopause | 1 | 2014 | 142 | 0.420 |
Why?
|
| Affect | 3 | 2015 | 1494 | 0.410 |
Why?
|
| Valerian | 1 | 2011 | 4 | 0.390 |
Why?
|
| Methyltestosterone | 2 | 2001 | 19 | 0.380 |
Why?
|
| Vasomotor System | 1 | 2012 | 208 | 0.380 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2010 | 36 | 0.350 |
Why?
|
| Hormone Replacement Therapy | 3 | 2001 | 750 | 0.350 |
Why?
|
| Personality | 1 | 2014 | 560 | 0.350 |
Why?
|
| Attention | 3 | 2017 | 2413 | 0.350 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2010 | 16 | 0.340 |
Why?
|
| Arousal | 7 | 2006 | 1174 | 0.340 |
Why?
|
| Cyclohexanols | 1 | 2010 | 126 | 0.340 |
Why?
|
| Sleep Deprivation | 3 | 2006 | 848 | 0.330 |
Why?
|
| Cognition | 4 | 2017 | 7057 | 0.300 |
Why?
|
| Plant Extracts | 1 | 2011 | 496 | 0.290 |
Why?
|
| Citalopram | 1 | 2010 | 402 | 0.280 |
Why?
|
| Women's Health | 2 | 2015 | 2081 | 0.270 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2005 | 1204 | 0.270 |
Why?
|
| Depression | 10 | 2018 | 8225 | 0.260 |
Why?
|
| Health Status | 3 | 2016 | 4087 | 0.230 |
Why?
|
| Self Report | 1 | 2015 | 3771 | 0.220 |
Why?
|
| Estrogens, Conjugated (USP) | 3 | 2001 | 274 | 0.210 |
Why?
|
| Mood Disorders | 1 | 2010 | 1127 | 0.210 |
Why?
|
| Self-Assessment | 2 | 2004 | 400 | 0.200 |
Why?
|
| Circadian Rhythm | 12 | 2010 | 2590 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2010 | 6020 | 0.200 |
Why?
|
| Sleep Stages | 7 | 1995 | 705 | 0.180 |
Why?
|
| Testosterone Congeners | 1 | 2001 | 62 | 0.180 |
Why?
|
| Dementia | 4 | 2024 | 2741 | 0.180 |
Why?
|
| Blood Pressure | 1 | 2016 | 8533 | 0.170 |
Why?
|
| Neuropsychological Tests | 5 | 2021 | 7119 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2017 | 3967 | 0.160 |
Why?
|
| Progesterone | 2 | 2001 | 752 | 0.160 |
Why?
|
| Estrogens | 3 | 2001 | 1528 | 0.150 |
Why?
|
| Pandemics | 1 | 2018 | 8734 | 0.150 |
Why?
|
| Somatoform Disorders | 1 | 2001 | 425 | 0.140 |
Why?
|
| Female | 54 | 2018 | 396532 | 0.140 |
Why?
|
| Ethics, Medical | 2 | 2000 | 785 | 0.130 |
Why?
|
| Humans | 76 | 2024 | 766812 | 0.130 |
Why?
|
| Caffeine | 3 | 2010 | 702 | 0.130 |
Why?
|
| Psychiatry | 3 | 2000 | 1715 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2000 | 935 | 0.120 |
Why?
|
| Philosophy | 1 | 1993 | 69 | 0.110 |
Why?
|
| Consciousness Disorders | 1 | 1997 | 445 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 4810 | 0.100 |
Why?
|
| Behavioral Research | 1 | 1992 | 52 | 0.100 |
Why?
|
| Narcolepsy | 2 | 1986 | 200 | 0.100 |
Why?
|
| Polysomnography | 2 | 1997 | 1868 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 4045 | 0.090 |
Why?
|
| Avoidance Learning | 2 | 1986 | 248 | 0.090 |
Why?
|
| Personality Inventory | 2 | 2010 | 1019 | 0.090 |
Why?
|
| Research Subjects | 1 | 1992 | 248 | 0.090 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2010 | 133 | 0.080 |
Why?
|
| Middle Aged | 29 | 2024 | 223267 | 0.080 |
Why?
|
| Fibromyalgia | 1 | 1993 | 407 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 5 | 1995 | 1193 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2000 | 1728 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 1324 | 0.080 |
Why?
|
| Aged | 20 | 2024 | 171344 | 0.070 |
Why?
|
| Work Schedule Tolerance | 1 | 1991 | 553 | 0.070 |
Why?
|
| Hydromorphone | 2 | 1987 | 70 | 0.070 |
Why?
|
| Electroencephalography | 7 | 2001 | 6282 | 0.070 |
Why?
|
| Institutionalization | 1 | 1987 | 108 | 0.070 |
Why?
|
| Antidepressive Agents | 6 | 2010 | 2903 | 0.070 |
Why?
|
| Adenoma | 2 | 2017 | 2155 | 0.070 |
Why?
|
| Anxiety | 2 | 2001 | 4668 | 0.070 |
Why?
|
| Electroconvulsive Therapy | 4 | 1980 | 505 | 0.070 |
Why?
|
| Sleep Arousal Disorders | 1 | 2006 | 12 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12064 | 0.070 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 1989 | 278 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 1993 | 1540 | 0.060 |
Why?
|
| Informed Consent | 1 | 1992 | 1010 | 0.060 |
Why?
|
| Temazepam | 1 | 1985 | 6 | 0.060 |
Why?
|
| Triazolam | 1 | 1985 | 16 | 0.060 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2077 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3078 | 0.060 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1985 | 66 | 0.060 |
Why?
|
| Respiratory System | 1 | 1988 | 562 | 0.060 |
Why?
|
| Memory | 2 | 2017 | 2192 | 0.060 |
Why?
|
| Sleep, REM | 6 | 1981 | 593 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2001 | 2105 | 0.060 |
Why?
|
| Alpha Rhythm | 3 | 1993 | 107 | 0.060 |
Why?
|
| Universities | 1 | 2010 | 1004 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 3111 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1988 | 0.050 |
Why?
|
| Ohio | 1 | 2004 | 320 | 0.050 |
Why?
|
| Trazodone | 1 | 1983 | 67 | 0.050 |
Why?
|
| Health Behavior | 1 | 1994 | 2649 | 0.050 |
Why?
|
| Glioma | 1 | 2018 | 3498 | 0.050 |
Why?
|
| Anti-Anxiety Agents | 1 | 1985 | 404 | 0.050 |
Why?
|
| Pain | 2 | 1993 | 5098 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2006 | 793 | 0.050 |
Why?
|
| Research | 2 | 2010 | 1977 | 0.050 |
Why?
|
| Phototherapy | 2 | 1995 | 368 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 1986 | 1838 | 0.050 |
Why?
|
| Catatonia | 2 | 1977 | 181 | 0.050 |
Why?
|
| Esterification | 1 | 2001 | 39 | 0.050 |
Why?
|
| Adult | 29 | 2006 | 223305 | 0.050 |
Why?
|
| Medroxyprogesterone | 1 | 2001 | 33 | 0.050 |
Why?
|
| Hippocampus | 2 | 1986 | 3776 | 0.040 |
Why?
|
| Students | 1 | 2010 | 1741 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2006 | 1441 | 0.040 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1980 | 133 | 0.040 |
Why?
|
| Depressive Disorder | 3 | 2006 | 3715 | 0.040 |
Why?
|
| Pedophilia | 1 | 1978 | 7 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2015 | 81657 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 1986 | 1407 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 10384 | 0.040 |
Why?
|
| Relaxation Therapy | 3 | 1995 | 180 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1980 | 2257 | 0.040 |
Why?
|
| Hypogonadism | 2 | 1981 | 802 | 0.040 |
Why?
|
| Brain Neoplasms | 2 | 2018 | 9101 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2001 | 12430 | 0.040 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 1977 | 39 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 1992 | 4421 | 0.030 |
Why?
|
| Male | 31 | 2006 | 364154 | 0.030 |
Why?
|
| Random Allocation | 1 | 2001 | 2394 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1977 | 289 | 0.030 |
Why?
|
| Public Opinion | 1 | 2000 | 484 | 0.030 |
Why?
|
| Dreams | 1 | 1977 | 145 | 0.030 |
Why?
|
| Hospitals, General | 1 | 1980 | 804 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 2017 | 328 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 13090 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15831 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 1975 | 120 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3431 | 0.030 |
Why?
|
| Research Design | 1 | 2010 | 6206 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 1976 | 306 | 0.030 |
Why?
|
| Time Factors | 6 | 2001 | 40149 | 0.030 |
Why?
|
| Adolescent | 7 | 2010 | 88902 | 0.030 |
Why?
|
| Wakefulness | 2 | 1993 | 1282 | 0.030 |
Why?
|
| Biological Psychiatry | 1 | 1993 | 27 | 0.030 |
Why?
|
| Massachusetts | 2 | 2004 | 8890 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4853 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4019 | 0.030 |
Why?
|
| Movement Disorders | 1 | 1977 | 462 | 0.030 |
Why?
|
| Feedback | 2 | 1973 | 797 | 0.030 |
Why?
|
| Piperazines | 1 | 1983 | 2547 | 0.030 |
Why?
|
| Electroshock | 2 | 1986 | 120 | 0.020 |
Why?
|
| Motor Activity | 1 | 2001 | 2711 | 0.020 |
Why?
|
| Head | 1 | 1977 | 926 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2001 | 6329 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1972 | 241 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1972 | 357 | 0.020 |
Why?
|
| Music | 1 | 1993 | 248 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 1971 | 166 | 0.020 |
Why?
|
| Tryptophan | 1 | 1972 | 484 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8045 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 529 | 0.020 |
Why?
|
| Urination Disorders | 1 | 1971 | 236 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1975 | 2677 | 0.020 |
Why?
|
| Melatonin | 1 | 1995 | 670 | 0.020 |
Why?
|
| Periodicity | 1 | 1971 | 347 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 1975 | 1008 | 0.020 |
Why?
|
| Fetus | 2 | 1975 | 1878 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 2 | 1981 | 731 | 0.020 |
Why?
|
| Methaqualone | 1 | 1987 | 4 | 0.020 |
Why?
|
| Luteinizing Hormone | 2 | 1981 | 828 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14762 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 2 | 1986 | 1168 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 15912 | 0.020 |
Why?
|
| Trust | 1 | 1992 | 532 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2001 | 65286 | 0.020 |
Why?
|
| Convulsive Therapy | 1 | 1966 | 3 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1987 | 192 | 0.020 |
Why?
|
| Mental Disorders | 4 | 1980 | 6869 | 0.020 |
Why?
|
| Diazepam | 1 | 1987 | 215 | 0.020 |
Why?
|
| Hostility | 2 | 1985 | 185 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4252 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 222 | 0.020 |
Why?
|
| Somnambulism | 1 | 1985 | 13 | 0.020 |
Why?
|
| Stress, Psychological | 3 | 1976 | 4526 | 0.020 |
Why?
|
| Panic | 1 | 1985 | 103 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1999 | 8728 | 0.020 |
Why?
|
| Occupational Health | 1 | 1991 | 812 | 0.020 |
Why?
|
| Translating | 1 | 2006 | 144 | 0.010 |
Why?
|
| Family | 2 | 1991 | 3209 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1986 | 184 | 0.010 |
Why?
|
| Risk Factors | 2 | 2024 | 74889 | 0.010 |
Why?
|
| Half-Life | 1 | 1985 | 648 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 13476 | 0.010 |
Why?
|
| Heart Rate | 1 | 1976 | 4207 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1977 | 2596 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1995 | 2519 | 0.010 |
Why?
|
| Chronic Disease | 3 | 1988 | 9358 | 0.010 |
Why?
|
| Oxygen | 1 | 1995 | 4252 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 59939 | 0.010 |
Why?
|
| Sweden | 1 | 2006 | 1382 | 0.010 |
Why?
|
| Physical Exertion | 2 | 1976 | 667 | 0.010 |
Why?
|
| Anger | 1 | 1985 | 402 | 0.010 |
Why?
|
| Psychomotor Agitation | 1 | 1985 | 307 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1983 | 132 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 59548 | 0.010 |
Why?
|
| Psychotherapy | 2 | 1983 | 1648 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1994 | 3240 | 0.010 |
Why?
|
| Climacteric | 1 | 1981 | 57 | 0.010 |
Why?
|
| MMPI | 1 | 1981 | 80 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1794 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 10580 | 0.010 |
Why?
|
| Electromyography | 2 | 1977 | 1398 | 0.010 |
Why?
|
| Wechsler Scales | 2 | 1983 | 256 | 0.010 |
Why?
|
| Hypertension | 1 | 1980 | 8616 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 1065 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1986 | 2341 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1983 | 779 | 0.010 |
Why?
|
| Health Policy | 1 | 1991 | 2697 | 0.010 |
Why?
|
| Methylphenidate | 1 | 1983 | 480 | 0.010 |
Why?
|
| Prolactin | 1 | 1980 | 628 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 1045 | 0.010 |
Why?
|
| United States | 2 | 2000 | 72945 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 520 | 0.010 |
Why?
|
| Child | 2 | 1997 | 80670 | 0.010 |
Why?
|
| Macaca | 1 | 1979 | 413 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6214 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54872 | 0.010 |
Why?
|
| Behavior | 1 | 1979 | 538 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 186 | 0.010 |
Why?
|
| Brain | 2 | 1973 | 27158 | 0.010 |
Why?
|
| Age Factors | 4 | 1980 | 18397 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 1975 | 87 | 0.010 |
Why?
|
| Brain Damage, Chronic | 1 | 1976 | 265 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1980 | 748 | 0.010 |
Why?
|
| Relaxation | 1 | 1975 | 51 | 0.010 |
Why?
|
| Homosexuality | 1 | 1975 | 268 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1983 | 1885 | 0.010 |
Why?
|
| Psychophysiologic Disorders | 1 | 1976 | 222 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1975 | 1309 | 0.010 |
Why?
|
| Electrooculography | 1 | 1973 | 112 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1983 | 1516 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1976 | 538 | 0.010 |
Why?
|
| Heart Block | 1 | 1975 | 391 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1972 | 36 | 0.010 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1972 | 38 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1988 | 39312 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1975 | 337 | 0.010 |
Why?
|
| Psychopathology | 1 | 1975 | 434 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10619 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1976 | 772 | 0.010 |
Why?
|
| Spironolactone | 1 | 1975 | 415 | 0.010 |
Why?
|
| Personality Disorders | 1 | 1976 | 727 | 0.010 |
Why?
|
| Mental Health | 1 | 2006 | 3269 | 0.010 |
Why?
|
| Diuresis | 1 | 1971 | 107 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1971 | 189 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6597 | 0.010 |
Why?
|
| Dogs | 1 | 1976 | 3834 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1992 | 24299 | 0.010 |
Why?
|
| Appetite | 1 | 1972 | 247 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 1971 | 195 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1972 | 347 | 0.010 |
Why?
|
| Environment | 1 | 1976 | 1120 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1980 | 2694 | 0.010 |
Why?
|
| Meningioma | 1 | 1978 | 1221 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1978 | 1255 | 0.010 |
Why?
|
| Psychological Tests | 2 | 1983 | 642 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1972 | 418 | 0.010 |
Why?
|
| Animals | 6 | 1986 | 168939 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2006 | 22248 | 0.000 |
Why?
|
| Potassium | 1 | 1972 | 1314 | 0.000 |
Why?
|
| Schizophrenia | 1 | 1966 | 6976 | 0.000 |
Why?
|
| Fatigue | 1 | 1975 | 1555 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1972 | 732 | 0.000 |
Why?
|
| Acute Disease | 1 | 1977 | 7240 | 0.000 |
Why?
|
| Gestational Age | 1 | 1975 | 3617 | 0.000 |
Why?
|
| Eating | 1 | 1972 | 1539 | 0.000 |
Why?
|
| Alcoholism | 1 | 1976 | 1980 | 0.000 |
Why?
|
| Primary Health Care | 1 | 1979 | 4735 | 0.000 |
Why?
|
| Psychotic Disorders | 1 | 1976 | 3275 | 0.000 |
Why?
|
| Smoking | 1 | 1976 | 9077 | 0.000 |
Why?
|
| Emotions | 1 | 1971 | 2758 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1978 | 11514 | 0.000 |
Why?
|
| Pregnancy | 2 | 1975 | 30236 | 0.000 |
Why?
|
| Higher Nervous Activity | 1 | 1976 | 4 | 0.000 |
Why?
|
| Digitalis Glycosides | 1 | 1976 | 47 | 0.000 |
Why?
|
| Placebos | 1 | 1980 | 1659 | 0.000 |
Why?
|
| Phenytoin | 1 | 1976 | 189 | 0.000 |
Why?
|
| Aggression | 1 | 1979 | 748 | 0.000 |
Why?
|
| Hypospadias | 1 | 1975 | 98 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1972 | 6359 | 0.000 |
Why?
|
| Propranolol | 1 | 1976 | 493 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1980 | 2350 | 0.000 |
Why?
|
| Thinking | 1 | 1976 | 320 | 0.000 |
Why?
|
| Interview, Psychological | 1 | 1976 | 810 | 0.000 |
Why?
|
| Rats | 2 | 1980 | 23717 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1983 | 12985 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1976 | 2253 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1976 | 6306 | 0.000 |
Why?
|
| Recurrence | 1 | 1976 | 8507 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1976 | 6408 | 0.000 |
Why?
|
| Coronary Disease | 1 | 1976 | 5915 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1976 | 3683 | 0.000 |
Why?
|